Advanced Search

Study Preview



Study Title and Description

Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis.



Key Questions Addressed
6 Key Question 6. What is the effectiveness of currently recommended antiviral treatments in improving health outcomes in patients with HCV infection?
  • Comments Comments (
    0
    ) |
7 Key Question 7. What is the effectiveness of currently recommended antiviral treatments in achieving a SVR in patients with HCV infection?
  • Comments Comments (
    0
    ) |
8 Key Question 8. What are the harms of currently recommended antiviral treatments?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis.
Author Chayama K., Suzuki F., Karino Y., Kawakami Y., Sato K., Atarashi T., Naganuma A., Watanabe T., Eguchi Y., Yoshiji H., Seike M., Takei Y., Kato K., Alves K., Burroughs M., Redman R., Pugatch DL., Pilot-Matias TJ., Krishnan P., Oberoi RK., Xie W., Kumada H.
Country Hiroshima University Hospital, Hiroshima, Japan. chayama@hiroshima-u.ac.jp.
Year 2018
Numbers Pubmed ID: 28948366

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Key Questions 1-9


Results & Comparisons

No Results found.